Open Orphan - Completion of Acquisition

Cathal Friel, Chief Executive of Open Orphan, discusses the acquisition of hVIVO including the deal itself, management team, and synergies with Open Orphan. hVIVO is a differentiated clinical development services business pioneering human disease models based upon viral challenge and leading the way in the use of human challenge studies to establish early proof-of-concept.

Cathal Friel

Company Events - OPEN ORPHAN

Open Orphan Presentation

Cathal Friel, CEO

Wed, 9 Oct 2019, 7:00am BST